combination

XED Welcomes Back Technology Visionary Mrinal Srivastava as Chief Technology Officer

NEW YORK and MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- XED is proud to announce the return of Mrinal Srivastava as…

1 day ago

IndoSpace expands presence with new 66-Acre Park in Maharashtra’s industrial and warehousing hub, Bhiwandi

MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- IndoSpace, India's fully integrated supply chain infrastructure services platform, has launched its new logistics…

2 days ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

1 week ago

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…

2 weeks ago

Olympism365: Six innovators awarded grants to advance UN SDGs through combination of sport and technology

16 September 2025 – Six recipients have received Tech365 Incubate grants, each worth up to USD 40,000, the International Olympic…

2 weeks ago

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…

2 months ago

A23 launches the 3rd season of Rummy Indian Open with a 25 Crore prize pool and a high-stakes finale in Goa

Spanning over two months, RIO is a combination of a tournament and a leaderboard culminating in an offline finale NEW…

2 months ago

Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ -- Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the…

2 months ago

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…

2 months ago